SuperworthZenas BioPharma market cap ZBIO
Share price times shares outstanding: what the whole company sells for, since 2024.
- Today, Oct 23, 2026
- $1.8B
- Highest close in our data
- $2.3B
- Dec 2025
Zenas BioPharma is worth $1.8B at the close on Oct 23, 2026, at $26.87 a share.
That is up 74% over the last year.
Its highest close in our data was $2.3B in Dec 2025.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $1.8B | $863.2M | $2.1B | −23% |
| 2025 | $2.3B | $291.3M | $2.3B | +455% |
| 2024 | $411.2M | $372.8M | $715M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Zenas BioPharma's size, closest first, today.
| Company | Market cap |
|---|---|
| ZBIOZenas BioPharma | $1.8B |
| ANIPANI Pharmaceuticals | $1.7B |
| PAHCPhibro Animal Health | $1.6B |
| HRMYHarmony Biosciences | $2.1B |
| ANABAnaptysbio | $1.5B |
| PCRXPacira BioSciences | $1.5B |
| PBHPrestige Consumer Healthcare | $2.3B |
| OMEROmeros | $1.2B |
| NRIXNurix Therapeutics | $2.8B |
| AMPHAmphastar Pharmaceuticals | $1.1B |
| OGNOrganon | $3.6B |
| Peer median | $1.6B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Zenas BioPharma
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.